Previous studies have shown that the upregulation of SLC7A11 is associated with poor prognosis of HCC, while the downregulation of SLC7A11 can inhibit the growth of HCC (Guo et al., 2011; Kinoshita et al., 2013). This evidence concerns the gene SLC7A11 and hepatocellular carcinoma.